🦊/Investors

Fidelity Investments

Institutional investoroperating company · company profile

Boston · 10 people tracked

Also known as FIAM LLC · FIDELITY DIVERSIFYING SOLUTIONS LLC · FIDELITY INSTITUTIONAL WEALTH ADVISER LLC · FIDELITY MANAGEMENT & RESEARCH COMPANY LLC · STRATEGIC ADVISERS LLC

Find your way into Fidelity Investments

6,885 people in our graph share verified history with the Fidelity Investments team — schools, employers, funds. One of them is your warm intro.

Chris Bischoffunlockedknows Tom Jessop · together at Goldman Sachs (overlapped)
knows the team · via The Predictive Index
×3knows the team · via Y Combinator
×6knows the team · via Goldman Sachs
knows the team · via Harvard University
Fox Verdict
Sign up to see your fit

Investment thesis

Fidelity Investments is a U.S.-based diversified financial services company whose stated mission is to help customers and clients achieve their financial objectives.

Source: firm website, verified Sep 15, 2026.

HQ
Boston, MA, US
Founded
1946
Last 12 months
24 investments
AUM
$5.7T
Tracked investments
117
Unicorns
28
IPOs
17
Acquisitions
5

Team · 10 people

from curated

59 people who came through Fidelity Investments went on to found or lead other companies.

+ 47 more

What they invest in

from 109 of 117 portfolio companies

Biotech ×37Healthtech ×33AI & Machine Learning ×31Enterprise Software ×21Deep Tech ×20Medical Devices ×19SaaS ×19Digital Health ×11

HQs:United States×85Canada×2Belgium×1Brazil×1Cyprus×1Germany×1

Investments · 117 tracked

founders shown can be your intro path

By year:2026 · 172025 · 192024 · 72023 · 52022 · 82021 · 112020 · 32019 · 12017 · 12016 · 22015 · 579 dated

Adagio TherapeuticsNASDAQ: IVVDApr 2021 · $336M

Invivyd develops monoclonal antibody therapies to prevent and treat serious viral infections, beginning with COVID-19 and expanding to respiratory syncytial virus and measles.

BiotechWaltham, US

Tillman U. Gerngross(Executive Officer, Director)Lynn Connolly(Executive Officer)Eric Kimble(Executive Officer)inHalley Gilbert(Executive Officer)Rebecca Dabora(Executive Officer)inEllie Hershberger(Executive Officer)

Co-investorsForesite CapitalGV (Google Ventures)MITHRILMithril Capital ManagementOrbiMedPolaris Partners+3 more

Atara Biotherapeuticsatarabio.comin𝕏NASDAQ: ATRA

Atara Biotherapeutics develops allogeneic T-cell immunotherapies using its proprietary EBV T-cell platform to harness the immune system for treating disease.

BiotechHealthtechMedical DevicesThousand Oaks, US

AnhCo Nguyen(President and Chief Executive Officer)

Co-investorsDag VenturesEcoR1 CapitalHEALTHCARE ROYALTY PARTNERSKleiner PerkinsDomain Associates

Clarivateclarivate.comin𝕏NYSE: CLVT

Clarivate is a global provider of enriched data, insights, analytics, workflow solutions and expert services serving academia, government, intellectual property, and life sciences sectors.

BiotechData & InfrastructureEdTechEnterprise SoftwareHealthtechSaaS

Matti Shem Tov(Chief Executive Officer)in

Co-investorsLeonard GreenACE & CompanyT. Rowe Price

DoorDashdoordash.comin𝕏NASDAQ: DASH

DoorDash operates a restaurant delivery platform that connects customers with dining establishments across hundreds of cities in North America through a logistics network.

ConsumerE-commerceFoodTechMarketplacesSan Francisco, US

Tony Xu(Co-founder & CEO)inAndy Fang(Co-founder & CTO)inStanley Tang(Co-founder & CPO)inGergely Nemeth(Senior Engineering Manager)in

Co-investorsA*BoxGroupBrave CapitalCoatue ManagementCRV (Charles River Ventures)Day One Ventures+27 more

DoorDashdoordash.newsin𝕏NASDAQ: DASH

DoorDash operates an on-demand delivery platform that connects consumers with restaurants, retailers, grocers, and other merchants for food and goods delivery.

E-commerceLogistics & Supply ChainMarketplaces

Tony Xu(Chief Executive Officer, Co-Founder, Chair, and Director)inRavi Inukonda(Chief Financial Officer)inPrabir Adarkar(Chief Operating Officer and President)inKeith Yandell(Chief Business Officer)in

Co-investorsFundersClub

Fate Therapeuticsfatetherapeutics.comNASDAQ: FATE

Fate Therapeutics develops investigational cellular immunotherapies to treat autoimmune diseases and cancer.

BiotechDigital HealthHealthtechMedical DevicesSan Diego, US

Christian Weyer(Executive Officer, Director)J. Scott Wolchko(Executive Officer)Daniel Shoemaker(Executive Officer)inBahram (Bob) Valamehr(President & Chief Executive Officer)inBahram Valamehr(President, Chief Executive Officer, and Director)in

BoardAmir Nashat(Director)in

Co-investorsSanofi VenturesVenrockOVP Venture PartnersPolaris Partners

Figmafigma.comin𝕏NYSE: FIG

Figma is a collaborative design platform that enables teams to create apps, websites, and products through shared design tools integrated with development workflows and AI-powered design assistance.

Developer ToolsSaaSSan Francisco, US

Evan Wallace(Co-Founder (former Chief Technology Officer))Dylan Field(Co-founder & CEO)inPraveer Melwani(Chief Financial Officer & Treasurer)inKris Rasmussen(Chief Technology Officer)inShaunt Voskanian(Chief Revenue Officer)inBrendan Mulligan(General Counsel & Secretary)in

Co-investors137 Ventures1517Alkeon InnovationAmplify.LAAndreessen HorowitzAtlassian Ventures+42 more

Intellia Therapeuticsintelliatx.comin𝕏NASDAQ: NTLAAug 2015

Intellia Therapeutics develops in vivo and ex vivo CRISPR/Cas9 gene editing therapies aimed at treating the root causes of severe genetic diseases, with lead candidates for hereditary angioedema and ATTR amyloidosis.

BiotechDeep TechHealthtechCambridge, US

Nessan Bermingham(Executive Officer, Director)inJennifer Doudna(Co-founder)Jose Rivera(Executive Officer)inJohn Leonard(President and Chief Executive Officer)inJames Basta(Executive Vice President, General Counsel and Corporate Secretary)inEdward Dulac(Executive Vice President, Chief Financial Officer)in

Co-investorsage1Atlas VentureAvoro Capital AdvisorsEcoR1 CapitalForesite CapitalOrbiMed

Lyftlyft.com𝕏NASDAQ: LYFT

Lyft is an on-demand ridesharing platform that connects passengers with drivers for various ride types, including standard rides, premium options, and other transportation services.

ConsumerEnterprise SoftwareMarketplacesMobility & TransportationSaaSSan Francisco, US

Logan Green(Co-founder & CEO)inJohn Zimmer(Co-founder & President)inDavid Risher(CEO)in

Co-investorsAglae VenturesAllied Venture PartnersAlpha Wave GlobalAndreessen HorowitzAutotech VenturesBling Capital+43 more

Meeshomeesho.comin𝕏NSE: MEESHO

Meesho operates an online marketplace that connects small businesses and individual entrepreneurs with customers across India, offering logistics, payments, and support services to help sellers manage their operations.

E-commerceEnterprise SoftwareBengaluru, IN

Vidit Aatrey(Founder/CEO)inSanjeev Barnwal(Founder/CTO)inSanjeev Kumar(Executive Officer, Director)Jatin Mazalcar(Executive Officer)in

BoardSumer Juneja(Director)inMohit Bhatnagar(Director)in

Co-investorsB Capital GroupB4 CapitalElevation CapitalGood CapitalInvestopadLeo Capital Ventures+15 more

Outset Medicaloutsetmedical.cominNASDAQ: OM

Outset Medical develops dialysis technology aimed at driving broader adoption and lowering the cost of care for patients and healthcare providers.

Enterprise SoftwareHardwareHealthtechMedical DevicesSan Jose, US

Nabeel Ahmed(Executive Officer)inMarc Nash(Executive Officer)inJohn Brottem(General Counsel)inLeslie Trigg(Chair and CEO)inJeff Mack(Executive Officer)inRenee Gaeta(Chief Financial Officer)in

Co-investorsThe Vertical GroupDurable Capital PartnersT. Rowe PriceWarburg Pincus

Parabilis Medicinesparabilismed.cominNASDAQ: PBLSJan 2026

Helicons develops a peptide-based therapeutic platform designed to target intracellular proteins previously considered undruggable by combining the specificity of antibodies with the cell-penetrating properties of small molecules.

AI & Machine LearningBiotechDeep TechMedical Devices

Mathai Mammen(CEO, President and Chairman)in

Co-investorsARCH Venture PartnersCatalio Capital Management, LPForesite CapitalFrazier Life SciencesGeneral CatalystNextech Invest+7 more

Seres Therapeuticsserestherapeutics.comin𝕏NASDAQ: MCRB

Seres Therapeutics is a clinical-stage biotechnology company developing therapies composed of rationally selected live bacterial consortia to treat serious diseases through modulation of the human microbiome.

BiotechDigital HealthHealthtechMedical DevicesCambridge, US

Matthew Henn(President and Chief Scientific Officer)inJohn Aunins(Executive Officer)inEric D. Shaff(Executive Officer)inDavid Cook(Executive Officer)inRoger J. Pomerantz(Executive Officer, Director)inRichard N. Kender(Executive Chair and Interim Chief Executive Officer)

Co-investorsFlagship PioneeringRA CapitalSofinnova Ventures

Snapsnapchat.comNYSE: SNAPMay 2016

Snapchat is a mobile app for communicating with friends and family through photos and videos, featuring augmented-reality Lenses, creative sharing tools, and a personalized map for discovering places and content.

ConsumerCreator EconomyMedia & EntertainmentSocialSanta Monica, US

Evan Spiegel(Co-founder and Chief Executive Officer)inBobby Murphy(Co-founder and Chief Technology Officer)Reggie Brown(Co-founder; former Chief Marketing Officer)Tim Sehn(Executive Officer)Emily White(Executive Officer)

BoardMitch Lasky(Director)in

Co-investorsA-Rod CorpAlibaba GroupCoatue ManagementEntrée CapitalGeneral AtlanticGeneral Catalyst+22 more

Space Xspacex.comNASDAQ: SPCX

Revolutionizing space technology to make life multi-planetary

Hawthorne, US

Elon Musk(Founder, CEO & Chief Engineer)inBret Johnsen(Executive Officer)inGwynne Shotwell(Executive Officer, Director)

BoardAntonio Gracias(Director)inSteve Jurvetson(Director)inDonald Harrison(Director)

Co-investors1/1 Capital137 Ventures2080 Ventures4DX Ventures7BC Venture CapitalA*+150 more

Spero Therapeuticssperotherapeutics.cominNASDAQ: SPRO

Spero Therapeutics is a clinical-stage biopharmaceutical company developing medicines for immune-mediated diseases, led by SP001, a third-generation anti-CD40L antibody targeting IgG4-related disease.

BiotechCambridge, US

Ankit Mahadevia(Executive Officer, Director)inStephen Garbacz(Executive Officer)inEsther Rajavelu(Director, President, Chief Executive Officer, Chief Financial Officer, Chief Business Officer and Treasurer)in

BoardJean-Francois Formela(Director)inReza Halse(Director)Casper Breum(Director)

Co-investorsHEALTHCARE ROYALTY PARTNERSMRL Ventures FundOUP (Osage University Partners)RA CapitalAlphabetAtlas Venture

Voyager Therapeutics, Inc.voyagertherapeutics.comNASDAQ: VYGR

Voyager Therapeutics is a biotechnology company developing genetic medicines for neurological diseases of the central nervous system, including Alzheimer's disease, ALS, and Parkinson's disease.

BiotechHealthtechLexington, US

Todd Carter(Executive Officer)inRobin Swartz(Executive Officer)inAlfred Sandrock(Executive Officer, Director)Peter Pfreundschuh(Executive Officer)inNathan Jorgensen(Chief Financial Officer; Principal Financial Officer and Principal Accounting Officer)Steven Hyman(Director)

Co-investorsARCH Venture PartnersThird Rock Ventures

Atom Ticketsatomtickets.comin𝕏Aug 2017✓ verified

Atom Tickets operates a social movie ticketing app and website that lets moviegoers browse films, watch trailers, buy tickets, invite friends to purchase their own tickets, and pre-order concessions for pickup at the theater.

ConsumerMarketplacesMedia & EntertainmentSanta Monica, US

Ameesh Paleja(Co-Founder)inMatthew Bakal(President, Treasurer and Manager)inGeoff Shaevitz(Co-Founder)inAllison Checchi(Chief Operating Officer)in

BoardChris Aronson(Manager)Jennifer Hollingsworth(Manager)

Co-investorsCerity Partners Ventures

EDXMedxmarkets.comin𝕏✓ verified

EDX Markets operates a Singapore-based perpetual futures trading venue for digital assets, focused on competition, transparency, and safety in crypto markets.

Crypto & Web3FintechSingapore, SG

Co-investorsPantera CapitalVirtu FinancialGSR

Endeavor Biomedicinesendeavorbiomedicines.comin𝕏✓ verified

Endeavor BioMedicines is a biopharmaceutical company developing medicines aimed at treating patients with serious, intractable diseases, with the goal of altering disease progression rather than only slowing it.

BiotechSan Diego, US

John Hood(Co-Founder, Chief Executive Officer & Executive Chairman)inWing Cheong Lam(Director)Bernard Davitian(Director)Raghu Saripalli(Executive Officer)Monal Mehta(Director)inMiguel de los Rios(Co-Founder & Chief Scientific Officer)in

Co-investorsLongitude CapitalOmega Funds

Medical Micro Instrumentsmmimicro.comin𝕏Feb 2024✓ verified

MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.

HealthtechMedical DevicesRoboticsJacksonville, US

Mark Toland(Executive Officer, Director)inAndrew Cleeland(Director)Justin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)

Co-investorsAndera PartnersBioStar CapitalDeerfield Management CompanyRA CapitalCorewell Health VenturesFountain Healthcare Partners

Silver Lakesilverlake.com✓ verified

Waymo develops the Waymo Driver, an autonomous vehicle system that provides ride-hailing services across multiple metropolitan areas.

AI & Machine LearningHardwareMobility & TransportationRoboticsSemiconductorsMountain View, US

Raghib Hussain(Chief Executive Officer)Tekedra MawakanaDmitri Dolgov

Co-investorsAlphabetAndreessen HorowitzBessemer Venture PartnersCapitalGDragoneer Investment GroupDST Global+9 more

23andMe23andme.comin𝕏Jun 2015Acquired

23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery.

BiotechDigital HealthDirect to ConsumerHealthtechLongevityMountain View, US

Anne Wojcicki(Co-founder & CEO)inLinda Avey(Co-founder)Paul Cheung(Co-founder)Andrew Page(Executive Officer, Director)Kathy Hibbs(Executive Officer)in

BoardEsther Dyson(Director)in

Co-investorsAllied Venture PartnersCivilization Ventures Management, LlcEQUIAMFirebolt Ventures Management Company, LlcG SquaredHouston Angel Network+13 more

Afferent PharmaceuticalsinJul 2015

BiotechSan Mateo, US

Anthony Ford(Executive Officer)inMichael Kitt(Executive Officer)inKathleen Sereda Glaub(Executive Officer, Director)in

BoardKevin Starr(Director)inArthur Pappas(Director)Liam Ratcliffe(Director)

Co-investorsPappas CapitalDomain AssociatesJennison AssociatesThird Rock Ventures

AgelessRxagelessrx.comin𝕏Aug 2026

AgelessRx offers prescription weight management medications delivered through a telehealth platform, including GLP-1 medications (semaglutide, tirzepatide), FDA-approved weight loss drugs (Wegovy, Zepbound), and supportive treatments like metformin and vitamin injections for adults seeking medically-supervised weight loss.

BiotechDigital HealthDirect to ConsumerHealthtechLongevityAnn Arbor, US

Anar Isman(Co-Founder & Chief Executive Officer)inRobert Michael Pejovich(Director of Finance of the Issuer)

Co-investors1/1 Capitalabrdn plcAngelini VenturesJanus Henderson InvestorsSanofi Ventures

Agomab Therapeuticsagomab.cominOct 2023 · $100M

Agomab is a clinical-stage biopharmaceutical company developing disease-modifying therapies for fibro-inflammatory and fibrotic diseases with high unmet medical need.

BiotechHealthtechMedical DevicesAntwerp, BE

Tim Knotnerus(Chief Executive Officer)in

Co-investorsEQT Life SciencesAdBio partnersAndera PartnersAsabys PartnersCanaan PartnersPontifax Venture Capital+1 more

Akouosakouos.comin

Akouos is a precision genetic medicine company developing therapies for the inner ear to restore, improve, and preserve hearing.

BiotechHealthtechBrookline, US

Emmanuel Simons(Executive Officer, Director)william sewell(Founder)in

BoardEd Mathers(Director)inKush Parmar(Director)in

Co-investors5AM VenturesEcoR1 CapitalNew Enterprise Associates (NEA)RA CapitalSofinnova VenturesCowen Healthcare Investments+1 more

Aledadealedade.comin𝕏Jun 2023 · $260M

Aledade is an accountable care organization (ACO) partner that works with primary care organizations to improve patient outcomes and healthcare quality.

Enterprise SoftwareHealthtechBethesda, US

Bijan Salehizadeh(Co-founder)inFarzad Mostashari(Chief Executive Officer and Co-Founder)inMat Kendall(President and Co-Founder)in

BoardRobert Kocher(Director)in

Co-investorsActivate Venture PartnersARCH Venture PartnersEcho Health VenturesGV (Google Ventures)Intrepid Growth PartnersIVP (Institutional Venture Partners)+12 more

Algoliaalgolia.comin𝕏Jul 2021

Algolia provides an API platform that enables developers to integrate search and discovery functionality into websites and mobile applications, serving thousands of companies across e-commerce, media, and SaaS.

AI & Machine LearningDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Nicolas Dessaigne(Founder/Board Member)inJulien Lemoine(Founder/CTO)in

BoardPhilippe Botteri(Director)in

Co-investors500 GlobalAccelAcequia Capital (AceCap)Aglae VenturesCollective LiquidityFounders Circle Capital+15 more

Ankyra Therapeuticsankyratx.comin𝕏Oct 2024

Ankyra Therapeutics is a biopharmaceutical company developing drugs, with a team that has collectively contributed to bringing seven drugs to global market approval.

BiotechDeep TechHealthtechMedical DevicesAustin, US

Tillman Gerngross(Executive Officer, Director)

BoardTerrance McGuire(Director)

Co-investorsGV (Google Ventures)Mithril Capital ManagementPolaris PartnersSands Capital VenturesSpring Mountain Capital

Anthropicanthropic.comin𝕏Sep 2025 · $13B

Anthropic is an AI safety research company that builds reliable, interpretable, and steerable AI systems.

AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareSan Francisco, US

Dario Amodei(Co-founder & CEO)inDaniela Amodei(Co-founder & President)inTom Brown(Co-founder)inJack Clark(Co-founder & Head of Policy)inJared Kaplan(Co-founder & Chief Science Officer)inChris Olah(Co-founder & Interpretability Research Lead)in

Co-investors3Comma Capital7BC Venture CapitalA.Capital VenturesAccelAlkeon InnovationAllen Institute for AI (AI2) Incubator+85 more

Applied Intuitionappliedintuition.comin𝕏

Applied Intuition develops physical AI software for autonomous and intelligent machines, including vehicles, robots, ships, and satellites across industries like automotive, defense, logistics, and manufacturing.

AI & Machine LearningDeep TechDeveloper ToolsEnterprise SoftwareRoboticsSunnyvale, US

Qasar Younis(Co-founder and CEO)inPeter Ludwig(Co-founder and CTO)in

Co-investors137 VenturesAndreessen HorowitzCoatue ManagementElad GilEQUIAMFloodgate+24 more

Astranisastranis.comin𝕏May 2026 · $300M

Astranis manufactures small, high-powered geosynchronous satellites equipped with advanced digital processing technology for global telecommunications and connectivity services.

Advanced ManufacturingDeep TechHardwareSpace TechSan Francisco, US

John Gedmark(Founder/CEO)inRyan McLinko(Founder/CTO)in

Co-investorsAndreessen HorowitzBlack FlagBoxGroupCantos VenturesCherubic VenturesCommonweal Ventures+39 more

Bain Capital Special Situationsbaincapitalspecialsituations.comin𝕏May 2025 · $2.1B

Bain Capital Special Situations is a private investment firm that combines private equity, private credit, and asset-backed capital to source and structure specialized deals across asset classes.

FintechSector AgnosticHong Kong, HK

Co-investorsBain Capital Double Impact Fund LPBain Capital Life SciencesBain Capital Tech OpportunitiesBain Capital VentureBain CapitalGallatin Point Capital

Benchlingbenchling.comin𝕏Apr 2016

Benchling provides a cloud-based R&D platform for life sciences, combining a collaborative electronic lab notebook, structured scientific data modeling, automated workflows, and AI tools.

AI & Machine LearningBiotechEnterprise SoftwareSaaSSan Francisco, US

Sajith Wickramasekara(Founder/CEO)inAshutosh Singhal(Director)Ashu Singhal(Founder)in

BoardMiles Grimshaw(Director)in

Co-investorsAlkeon InnovationAndreessen HorowitzArtisanal VenturesBalaji SrinivasanDraper AssociatesF-Prime Capital+15 more

Boltbolt.euin𝕏

Bolt operates a European mobility super-app offering ride-hailing, shared cars, e-scooters, and food and grocery delivery, along with on-demand parcel delivery.

Logistics & Supply ChainMarketplacesMobility & TransportationTallinn, EE

Co-investorsBADideas.fundKorelya CapitalRubyLightSpecialist VCSpring CapitalEuropean Investment Bank+3 more

Bolt Threadsboltthreads.comDefunct

Bolt Threads was a manufacturer of biomaterials for personal care formulations.

BiotechNew MaterialsFoxboro, US

Ethan Mirsky(Executive Officer)David Breslauer(Executive Officer, Director)Daniel Widmaier(Executive Officer, Director)

BoardJerry Fiddler(Director)Steven Vassallo(Director)inJim Kim(Director)

Co-investorsKicker VenturesKyber Knight CapitalMission Bay CapitalMission Biocapital8VCBaillie Gifford+4 more

Boostedboosted.aiinNov 2024 · $15M

Boosted.ai provides an AI platform for investment research that answers questions on stocks and themes and uses AI agents to generate reports and analysis for investment professionals.

AI & Machine LearningFintechSaaS

Joshua Pantony(Founder)inJon Dorando(Founder)in

Co-investorsDunamu & PartnersHarbourVest Partners (Canada)Portage VenturesSpark CapitalTen Coves Capital

Boweryboweryfarming.comMay 2021Defunct

Bowery Farming uses controlled environment agriculture to grow fresh produce locally in urban centers.

AgTechFoodTechNew York, US

Irving Fain(CEO & Founder)inChristopher Livingston(Executive Officer)Darren Thompson(Executive Officer)in

BoardAndy Wheeler(Director)Sara Robling(Director)Hans Tung(Director)in

Co-investorsEvolution VC PartnersHomebrewRed Swan VenturesRRE VenturesSand Hill AngelsSV Angel+10 more

Bright Peak Therapeuticsbrightpeaktx.cominJun 2021

Bright Peak Therapeutics is a biotechnology company developing multi-functional PD-1 inhibitors for cancer immunotherapy, based on its EDC protein-engineering platform.

BiotechHealthtechSan Diego, US

Vijaya Pattabiraman(Co-founder & Chief Technology Officer)inJeffrey Bode(Scientific co-founder; Professor at ETH Zürich)inFredrik Wiklund(Chief Executive Officer)Christine Siu(Director)Michael Rosenzweig(Director)Bertolt Kreft(Executive Officer)

Co-investorsRA CapitalJohnson & Johnson Innovation – JJDCVersant VenturesVenrockAlexandriaBlackRock+2 more

Cardurioncardurion.cominJul 2024 · $260M

Cardurion is a cardiovascular disease-focused company developing therapeutics, with a pipeline advanced through clinical development, trial design, regulatory affairs, and commercialization.

BiotechDigital HealthHealthtechMedical DevicesBurlington, US

Michael E. Mendelsohn(Founder and Chief Strategy Officer)inMichael Mendelsohn, M.D.(Founder)in

Co-investorsBain CapitalAscenta CapitalDelos CapitalDigitalis VenturesNew Enterprise Associates (NEA)Bain Capital Life Sciences+4 more

Castle Creek Biosciencescastlecreekbio.comin𝕏May 2022 · $112.8M

Castle Creek Biosciences develops re-dosable gene therapies for genetic diseases, with a lead candidate (D-Fi) in registrational clinical trials for dystrophic epidermolysis bullosa.

BiotechDeep TechMedical DevicesExton, US

Matthew Gantz(President and Chief Executive Officer)inDavid ChuinMichael TownsleyChristopher J. LarsoninRhea WilliamsinJude Sullivan(Executive Officer)

Co-investorsParagon Biosciences LLCValor Equity PartnersHorizon

Celestial AIcelestial.aiin𝕏Mar 2025 · $250M

The page describes Photonic Fabric, an optical interconnect technology platform for the scale-up interconnect market that enables high-bandwidth, power-efficient links for AI data center infrastructure.

AI & Machine LearningDeep TechSector AgnosticSemiconductorsSanta Clara, US

Preetinder Virk(Chief Operating Officer)David Lazovsky(President and Chief Executive Officer)inKelyn Brannon(Chief Financial Officer)Philip Winterbottom(Chief Technology Officer)in

BoardLip-Bu Tan(Director)Alonso Galvan(Director)

Co-investorsFitz Gate VenturesIAG Capital PartnersKoch Disruptive TechnologiesM VenturesSamsung Catalyst FundThe Engine Ventures+11 more

Cerebrasfoundationcapital.comin𝕏Sep 2025 · $1.1B

Foundation Capital is an early-stage venture capital firm that invests in founders at the idea stage, often as a company's first investor and in pre-revenue rounds.

San Francisco, US

Co-investorsFoundation Capital1789 CapitalAlpha Wave GlobalAltimeter CapitalAtreides ManagementBenchmark+2 more

CFO.airunway.comin𝕏Feb 2026 · $315M

Runway helps founders understand financial data and spreadsheets.

AI & Machine LearningEnterprise SoftwareFintechSaaS

Anastasis Germanidis(Founder)inCristóbal Valenzuela(Founder)inSiqi Chenin

BoardDylan FieldHenry Ward

Co-investors500 GlobalAndreessen HorowitzChamaeleonDreamers VCRain CapitalShrug Capital+7 more

Checkrcheckr.comin𝕏Sep 2021 · $250M

Checkr provides background verification and fraud detection services for hiring, loan approvals, insurance, and tenant screening decisions.

AI & Machine LearningEnterprise SoftwareHR TechSaaSSan Francisco, US

Daniel Yanisse(Founder/CEO)inJonathan Perichon(Founder)in

BoardAli Rowghani(Director)Richard Wong(Director)in

Co-investorsAccelActivant CapitalCoatue ManagementDCVC (Data Collective)Earl Grey CapitalGV (Google Ventures)+13 more

City Therapeuticscitytx.comin𝕏Oct 2024

City Therapeutics develops RNAi-based medicines targeting rare, specialty, and prevalent diseases using engineered trigger molecules and precision delivery ligands.

BiotechMedical DevicesCambridge, US

Mark Keating, MD(Co-founder)Kotaro Nakanishi, PhD(Co-founder)Yukihide Tomari, PhD(Co-founder)Phillip Zamore, PhD(Co-founder)

Co-investorsAN Venture PartnersARCH Venture PartnersSofinnova VenturesCasdin CapitalInvusRock Springs Capital

Corastonecorastone.usin

Corastone operates a platform for accessing and managing private market investments, aimed at helping firms handle more investors, counterparties, and complex investments.

Enterprise SoftwareFintechSaaS

Hamid Gayibov(Founder)in

Co-investorsMotive PartnersApolloFranklin TempletonHamilton Lane

Creditascreditas.comin𝕏Jan 2022 · $260M

Creditas is a Brazilian financial platform offering secured loans (using vehicles or real estate as collateral), payroll loans, auto and home financing, insurance, and flexible employee benefits.

ConsumerFintechInsurTech

Sergio Furio(Founder)in

Co-investorsAmadeus Capital PartnersHeadlineHeadline Growth Management, LLCKaszek VenturesLightrockMouro Capital+12 more

Databricksdatabricks.comin𝕏Sep 2025

Databricks provides a unified platform for data engineering, analytics, and artificial intelligence, enabling organizations to build and deploy data and AI applications on cloud infrastructure.

AI & Machine LearningCloud ComputingData & InfrastructureEnterprise SoftwareSan Francisco, US

Ali Ghodsi(Co-founder & CEO)inIon Stoica(Executive Officer, Director, Promoter)inMatei Zaharia(Executive Officer, Director, Promoter)inReynold Xin(Founder)inPatrick Wendell(Founder)inAndy Konwinski(Founder)in

Co-investors137 VenturesA.Capital VenturesAglae VenturesAlkeon InnovationAltra VentureAmplify Partners+73 more

Dermiradermira.com

HealthtechMenlo Park, US

Thomas G. Wiggans(Executive Officer, Director)inEugene A. Bauer(Executive Officer, Director)Andrew Guggenhime(Executive Officer)Luis Pena(Executive Officer)Christopher Griffith(Executive Officer)

BoardFred Craves(Director)in

Co-investorsAisling CapitalBay City CapitalCanaan PartnersForesite CapitalNew Enterprise Associates (NEA)Qiming Healthcare+1 more

Discorddiscord.comin𝕏Sep 2021

Discord is a communications platform for voice, video, and text chat designed primarily for gaming communities and players.

ConsumerCreator EconomyGamingSocialSan Francisco, US

Jason Citron(Co-founder)inStanislav Vishnevskiy(Co-founder and Chief Technology Officer)inClint Smith(Executive Officer)inHumam Sakhnini(Chief Executive Officer)Tomasz Marcinkowski(Chief Financial Officer)inBen Shanken(VP of Product)in

Co-investorsAccelAccess IndustriesAcrew CapitalAppWorks VenturesArcane GroupArrington Capital+37 more

Emalex Biosciencesemalexbiosciences.comin𝕏Nov 2022 · $250M

Emalex Biosciences is a clinical-stage biopharmaceutical company developing treatments for central nervous system disorders, including ecopipam, an investigational dopamine D1 receptor antagonist for pediatric Tourette syndrome.

BiotechMedical Devices

Co-investorsParagon Biosciences LLCBain Capital Life SciencesValor Equity Partners

Empowerempower.deliveryOct 2025 · $140M

Empower Delivery provides a timing and coordination software engine designed to optimize omnichannel operations for restaurant brands, enabling efficient order management and fulfillment across digital and in-person channels.

Enterprise SoftwareLogistics & Supply ChainSaaS

Dan McFaddeninChris PfeifferDavid BaldwininKristopher ChambersLisa SangiorgioNakul Deo

Co-investorsHigh AlphaAllos VenturesCapitalGIndex VenturesInnovation EndeavorsKnollwood Investment Advisory+2 more

Empowerempowersemi.cominOct 2025 · $140MAcquired

Empower Semiconductor designs power management and mixed-signal integrated circuits, including high-power and voltage regulation devices for the semiconductor industry.

AI & Machine LearningDeep TechHardwareSemiconductors

Tim Phillips(Chief Executive Officer & President, Founder)inGene Sheridan(Founder)inTrey Roessig(Chief Technology Officer & SVP Engineering)Kurt Redfield(Chief Financial Officer & Treasurer)

Co-investorsCapitalGRaptor GroupSamsung Catalyst FundSocratic PartnersAtreides ManagementIndex Ventures+6 more

Empowerempowercultura.esinOct 2025 · $140M

Empowercultural provides cultural accessibility solutions for museums, art centers, and cultural institutions, with a focus on ensuring people with autism and other needs can participate in cultural experiences without barriers.

EdTechImpact & Social GoodMadrid, ES

Co-investorsShip2BAtreides ManagementBlisceCapitalGCommunity Investment ManagementIcon Ventures+6 more

Enviseenvise.ioinJun 2023 · $154M

Envise provides interactive real estate solutions and property management tools for real estate companies and their customers throughout the property lifecycle.

PropTechSaaS

Anna Nordström(CEO)in

Co-investorsRound2 Capital PartnersGV (Google Ventures)T. Rowe PriceViking Global Investors

Epicgetepic.com𝕏Oct 2015

Epic! is a digital library platform that provides access to books and reading materials for educational institutions and individual readers.

Digital HealthEdTechMinot, US

Kevin DonahueinSuren MarkosianTodd Berning(Executive Officer)in

Co-investors500 GlobalMaven VenturesMenlo VenturesSocial StartsSpider CapitalStructural Capital+3 more

ErisXerisx.comin𝕏acquired by Cboe Global Markets

Crypto & Web3FintechChicago, US

Co-investorsConsenSys MeshDigital Currency GroupPantera CapitalValor Equity PartnersBitmain

Evozyneevozyne.cominSep 2023 · $81M

Evozyne designs and builds engineered protein therapeutics using an AI-native platform, focusing on treatments for immune-mediated diseases.

AI & Machine LearningBiotechDeep TechHealthtechChicago, US

Aris Theologis(Executive Officer, Director)inDarien Parhad(Executive Officer)Patrick J. Morris(Executive Officer, Director)Marc Yoskowitz(CEO)inRama Ranganathan(Executive Officer, Director)

BoardJeffrey S. Aronin(Director)

Co-investorsParagon Biosciences LLCOrbiMedNVenturesNVIDIAValor Equity Partners

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

Aristea TherapeuticsCastle Creek PharmaceuticalsMenlo MicrosystemsPronutria BiosciencesValenzaBioWasabi HoldingYumanity Therapeutics

Exits · 22

17 IPOs · 5 acquisitions · showing 19

Adagio TherapeuticsNASDAQ: IVVDAtara BiotherapeuticsNASDAQ: ATRAClarivateNYSE: CLVTDoorDashNASDAQ: DASHDoorDashNASDAQ: DASHFate TherapeuticsNASDAQ: FATEFigmaNYSE: FIGIntellia TherapeuticsNASDAQ: NTLALyftNASDAQ: LYFTMeeshoNSE: MEESHOOutset MedicalNASDAQ: OMParabilis MedicinesNASDAQ: PBLSSeres TherapeuticsNASDAQ: MCRBSnapNYSE: SNAPSpace XNASDAQ: SPCXSpero TherapeuticsNASDAQ: SPROVoyager Therapeutics, Inc.NASDAQ: VYGRErisXacq. by Cboe Global MarketsxAIacq. by Space X

Portfolio news

latest coverage across their companies

IPO stake values · per SEC filings · 7

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
Clarivate7.8%$22.50Jun 2020$676.3M
Atara Biotherapeutics4.8%$52.00Jul 2015$70.1M
Seres Therapeutics6.5%$18.00Jun 2015$44.4M
Intellia Therapeutics5.3%$18.00May 2016$33.3M
Voyager Therapeutics, Inc.6.0%$14.00Nov 2015$22M
Fate Therapeutics15.0%$6.00Oct 2013$17.2M
Spero Therapeutics4.4%$12.50Jul 2018$10M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has Fidelity Investments made?
Fidelity Investments has 117 tracked investments, 22 of which have exited, including 41 dated in the last 24 months.
What sectors does Fidelity Investments focus on?
Fidelity Investments focuses on Crypto & Web3.
Where is Fidelity Investments located?
Fidelity Investments is headquartered in Boston, US.
Does Fidelity Investments lead rounds?
Fidelity Investments has led 28 of the 74 rounds where its role is on record.
Who does Fidelity Investments co-invest with?
Fidelity Investments most often shares deals with Coatue Management, IVP (Institutional Venture Partners), General Catalyst, among 76 tracked co-investors.

Media · Podcasts & interviews

from their channel

Should You Get A Trump Account For Kids? | Fidelity Investments

Fidelity Investments

Do This To Protect Your Crypto In 2026 | Fidelity Investments

Fidelity Investments

Making Early Retirement A Reality | Insights Live℠ | Fidelity Investments

Fidelity Investments

How Is The Strait Of Hormuz Affecting The Stock Market? | In The Money | Fidelity Investments

Fidelity Investments

Why Emerging Markets Stocks Are So Strong Right Now - 7/21/26 | Market Sense | Fidelity Investments

Fidelity Investments

Generating Income From Your Portfolio | Insights Live℠ | Fidelity Investments

Fidelity Investments

Images

Fidelity Investments photo

Similar investors

Featured in lists